Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
30-Jun-24 | Interim | n/a | (2.82) | (80.00)p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | n/a | (1.49) | (160.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (2.10) | (200.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (5.11) | (280.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (3.99) | (200.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (6.70) | (240.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 315.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1,252.00 |
52 Week Low | 315.50 |
Volume | 0 |
Shares Issued | 3.60m |
Market Cap | £11.37m |
RiskGrade | 340 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
You are here: research